An overview of recent studies on the analysis of pharmaceutical polymorphs

N Chieng, T Rades, J Aaltonen - Journal of pharmaceutical and biomedical …, 2011 - Elsevier
Pharmaceutical solids are well known to be able to exist in different solid-state forms and
there are a wide variety of solid-state analytical techniques available to characterize …

Phase transition enthalpy measurements of organic and organometallic compounds and ionic liquids. Sublimation, vaporization, and fusion enthalpies from 1880 to …

W Acree, JS Chickos - Journal of Physical and Chemical Reference …, 2017 - pubs.aip.org
This compendium completes a previous report published in 2016 [2016ACR/CHI] on phase
change enthalpies. Paper I of this compendium includes over 6600 organic compounds …

[HTML][HTML] Cilostazol-loaded poly (ε-Caprolactone) electrospun drug delivery system for cardiovascular applications

M Rychter, A Baranowska-Korczyc, B Milanowski… - Pharmaceutical …, 2018 - Springer
Purpose The study discusses the value of electrospun cilostazol-loaded (CIL) polymer
structures for potential vascular implant applications. Methods Biodegradable …

[HTML][HTML] Freeze-drying of drug nanosuspension–study of formulation and processing factors for the optimization and characterization of redispersible cilostazol …

E Jakubowska, M Bielejewski, B Milanowski… - Journal of Drug Delivery …, 2022 - Elsevier
The aim of this work was to systematically study the effect of freeze-drying of bottom-up
processed cilostazol nanosuspension on the particle size after redispersion. Several …

The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol

Y Wang, L Sun, T Jiang, J Zhang, C Zhang… - Drug development …, 2014 - Taylor & Francis
Objective: To explore the suitable application of MCM-41 (Mobil Composition of Matter
number forty-one)-type and MCM-48-type mesoporous silica in the oral water insoluble drug …

Micronization of cilostazol using supercritical antisolvent (SAS) process: effect of process parameters

MS Kim, S Lee, JS Park, JS Woo, SJ Hwang - Powder Technology, 2007 - Elsevier
The aim of this study was to improve dissolution rate of poorly water-soluble drug, cilostazol,
using supercritical antisolvent (SAS) process. The effect of process variables, such as …

Solid-state of pharmaceutical compounds

D Giron, M Mutz, S Garnier - Journal of thermal analysis and …, 2004 - akjournals.com
Solid-state of pharmaceutical compounds Page 1 Journal of Thermal Analysis and Calorimetry,
Vol. 77 (2004) 709–747 SOLID-STATE OF PHARMACEUTICAL COMPOUNDS Impact of the …

A systematic approach to design and prepare solid dispersions of poorly water-soluble drug

S Verma, VS Rudraraju - AAPS PharmSciTech, 2014 - Springer
The objective of the present study was to define a systematic approach to design and
prepare solid dispersions of poorly water-soluble drug. The systematic approach can be …

Wetting kinetics: an alternative approach towards understanding the enhanced dissolution rate for amorphous solid dispersion of a poorly soluble drug

S Verma, VS Rudraraju - Aaps Pharmscitech, 2015 - Springer
Developing amorphous solid dispersions of water-insoluble molecules using polymeric
materials is a well-defined approach to improve the dissolution rate and bioavailability …

Electrospun poly (lactic acid)(PLA)/poly (butylene adipate-co-terephthalate)(PBAT) nanofibers for the controlled release of cilostazol

LR Antunes, GL Breitenbach, MCG Pellá… - International Journal of …, 2021 - Elsevier
Drug delivery devices are attractive alternatives to drugs usually orally administrated.
Therefore, this work aimed to produce PLA/PBAT-based nanofibers for the controlled …